Breadcrumb

Faculty News

S. Cenk Sahinalp elected to 2025 class of ISCB Fellows

S. Cenk Sahinalp, Ph.D., Senior Investigator in the Cancer Data Science Laboratory, was elected to the 2025 class of International Society for Computational Biology (ISCB) Fellows. The program recognizes individuals who have played a pivotal role in advancing bioinformatics and computational biology. Sahinalp is being honored for his work as a leader in algorithmic methods for cancer genomics, structural variation and tumor evolution. 

Read More

CCR researchers nominated to 2024 class of AAAS Fellows

Sheue-yann Cheng, Ph.D., Senior Investigator in the Laboratory of Molecular BiologyAnish Thomas, MBBS, M.D., Senior Investigator in the Developmental Therapeutics Branch, and Xin Wei Wang, Ph.D., Acting Co-Chief and Senior Investigator in the Laboratory of Human Carcinogenesis, were elected as 2024 Fellows to the American Association for the Advancement of Science (AAAS). Since 1874, the AAAS has elected scientists, engineers and innovators as Fellows for their achievements across many disciplines. Election as a Fellow honors members whose efforts on behalf of the advancement of science or its applications in service to society have distinguished them among their peers and colleagues.

Read More

Elaine Jaffe and Ira Pastan elected as 2025 Fellows of the AACR Academy

Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, and Ira Pastan, M.D., Chief Emeritus of the Laboratory of Molecular Biology, were elected in the 2025 class of Fellows of the American Association for Cancer Research (AACR) Academy. The mission of the Academy is to recognize and honor extraordinary scientists whose groundbreaking contributions have driven significant innovation and progress in the fight against cancer. Jaffe is being recognized for her revolutionary research efforts in hematopathology and transforming diagnostic standards and care for lymphoma and leukemia; Pastan is being recognized for his visionary contributions to cancer therapy and the field of receptor biology. 

Read More

Natasha Caplen appointed to Senior Investigator at CCR

The CCR community congratulates Natasha J. Caplen, Ph.D., who has been appointed Senior Investigator in the Genetics Branch. Caplen contributed to the discovery of RNA interference (RNAi) in mammalian cells and has pioneered approaches for exploiting this gene regulatory mechanism to investigate cancer biology and treatment. Her current studies focus on the functional genetic analysis of cancers driven by fusion oncogenes, particularly the pediatric tumor Ewing sarcoma.

Read More

Nirali Shah elected to the American Society for Clinical Investigation

Nirali N. Shah, M.D., M.H.Sc., Lasker Clinical Research Scholar in the Pediatric Oncology Branch, was elected as a member of the American Society for Clinical Investigation (ASCI). The organization seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve the health of all people. The 2025 newly elected members came from 46 different institutions and represent excellence across the breadth of academic medicine. 

Read More

Chuan Wu appointed to Senior Investigator at CCR

The CCR community congratulates Chuan Wu, M.D., Ph.D., who has been appointed Senior Investigator in the Experimental Immunology Branch. Wu studies the role of intestinal neuroimmune interactions in health and disease. His lab works to understand the cellular and molecular mechanisms of the dynamic interplay between the enteric nervous system and the immune system to build a comprehensive view of intestinal homeostasis and to discover new therapeutics for intestinal inflammatory diseases.

Read More

Daniel Larson appointed Chief of the Laboratory of Receptor Biology and Gene Expression

The CCR community congratulates Daniel R. Larson, Ph.D., who has been appointed Chief of the Laboratory of Receptor Biology and Gene Expression. Larson’s laboratory’s goal is to understand gene expression in eukaryotic cells, starting from the mechanistic behavior of individual macromolecules and proceeding to their regulation in cells and tissue. His current work is focused on applying experimental and theoretical approaches to the study of hematopoiesis in health and disease through the trans-NIH Myeloid Malignancies Program.

Read More